Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A computational strategy has delivered a redesigned, more stable version of a cytokine protein that mimics the natural protein’s interactions with receptors, opening the way for designer cytokine-based therapeutics.

Prof Yvonne Jones et al writing in Nature, describes how they have engineered a protein structure from scratch to replicate the beneficial receptor-binding properties of IL-2 without the drawbacks of the original cytokine.

Read the full article